The combined analysis of genomic alterations and tumour phenotypes, presented here, show that BRCA1- and BRCA2-related tumours develop largely through different genetic pathways in terms of the regions altered, while also displaying distinct phenotypes. This evidence concerns the gene BRCA1 and neoplasm.